Table 2.
Characterization of the 29 C. difficile isolates.
| Strain No. | Ward (No.) | T-MALDI (No.) | Ribotype (No.) | Gene Detection | SIR (MIC Range) | ||||
|---|---|---|---|---|---|---|---|---|---|
| tcdA (No.) | tcdB (No.) | cdtA/cdtB (No.) | Vancomycin | Metronidazole | Moxifloxacin | ||||
| 4 | LT (4) | RT 126 (4) | RT 126 (4) | Positive (4) | Positive (4) | Positive (4) | S (0.25–0.5) | S (0.125–0.25) | R (>32) |
| 17 | LT (17) | NP (1) | PR A (22) | Positive (22) | Negative (22) | Positive (22) | NP | NP | NP |
| PR5 (7) | S (0.032–0.5) |
S (0.125–0.25) |
R (>32) |
||||||
| PR5 LRC (4) | |||||||||
| NRC (3) | |||||||||
| PR2 (1) | |||||||||
| PR2 LRC (1) | |||||||||
| 5 | IM (5) | PR5 LRC (2) | |||||||
| NRC (2) | |||||||||
| PR5 (1) | |||||||||
| 2 | LT (1) | PR5 (1) | PR B (2) | Positive (2) | Positive (2) | Negative (2) | S (0.5) |
S (1) |
S (0.5) |
| IM (1) | NRC (1) | ||||||||
| 1 | IM (1) | PR2 LRC (1) | PR C (1) | Positive (1) | Positive (1) | Negative (1) | S (0.5) |
S (1) |
S (0.5) |
SIR: MIC interpretive categories, S: susceptible, R: resistant, LT: Long-term Care Unit; IM: Internal Medicine ward; LRC: low reliable classification; NRC: Not reliable classification; NP: Not performed.